Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Clinigen gets European license to Theravance's antibiotic Vibativ

Executive Summary

Theravance Inc. (focused on respiratory, infectious, neurological, and GI motility diseases) has licensed UK-based specialty pharmaco Clinigen Group PLC exclusive rights to commercialize the once-daily injectable antibiotic Vibativ (telavancin) in the EU and other European countries including Norway and Switzerland.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Marketing (Licensing)

Related Companies